The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Dehydroepiandrosterone (DHEA)-Global Market Insights and Sales Trends 2024
Synopsis
Dehydroepiandrosterone is a precursor hormone, which means it has little biological effect on its own, but has powerful effects when converted into other hormones such as testosterone and oestradiol.
The global Dehydroepiandrosterone (DHEA) market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Dehydroepiandrosterone (DHEA) in various end use industries. The expanding demands from the Food Industry, Pharmaceuticals Industry and Other,, are propelling Dehydroepiandrosterone (DHEA) market. Powder, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Tablets segment is estimated at % CAGR for the next seven-year period.
DHEA, the most abundant steroid in the blood of adult humans, peaks in early adulthood and declines with age.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Dehydroepiandrosterone (DHEA), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Dehydroepiandrosterone (DHEA) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Dehydroepiandrosterone (DHEA) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Dehydroepiandrosterone (DHEA) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Dehydroepiandrosterone (DHEA) covered in this report include Natrol, GNC, Nature’s Bounty, Jarrow Formulas, Acetar Bio-Tech, Shanghai Jinli Biotech, Lisi (Xian) Bio-Tech and Schiff Vitamins, etc.
The global Dehydroepiandrosterone (DHEA) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Natrol
GNC
Nature’s Bounty
Jarrow Formulas
Acetar Bio-Tech
Shanghai Jinli Biotech
Lisi (Xian) Bio-Tech
Schiff Vitamins
Global Dehydroepiandrosterone (DHEA) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Dehydroepiandrosterone (DHEA) market, Segment by Type:
Powder
Tablets
Other
Global Dehydroepiandrosterone (DHEA) market, by Application
Food Industry
Pharmaceuticals Industry
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Dehydroepiandrosterone (DHEA) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Dehydroepiandrosterone (DHEA) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Dehydroepiandrosterone is a precursor hormone, which means it has little biological effect on its own, but has powerful effects when converted into other hormones such as testosterone and oestradiol.
The global Dehydroepiandrosterone (DHEA) market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Dehydroepiandrosterone (DHEA) in various end use industries. The expanding demands from the Food Industry, Pharmaceuticals Industry and Other,, are propelling Dehydroepiandrosterone (DHEA) market. Powder, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Tablets segment is estimated at % CAGR for the next seven-year period.
DHEA, the most abundant steroid in the blood of adult humans, peaks in early adulthood and declines with age.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Dehydroepiandrosterone (DHEA), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Dehydroepiandrosterone (DHEA) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Dehydroepiandrosterone (DHEA) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Dehydroepiandrosterone (DHEA) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Dehydroepiandrosterone (DHEA) covered in this report include Natrol, GNC, Nature’s Bounty, Jarrow Formulas, Acetar Bio-Tech, Shanghai Jinli Biotech, Lisi (Xian) Bio-Tech and Schiff Vitamins, etc.
The global Dehydroepiandrosterone (DHEA) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Natrol
GNC
Nature’s Bounty
Jarrow Formulas
Acetar Bio-Tech
Shanghai Jinli Biotech
Lisi (Xian) Bio-Tech
Schiff Vitamins
Global Dehydroepiandrosterone (DHEA) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Dehydroepiandrosterone (DHEA) market, Segment by Type:
Powder
Tablets
Other
Global Dehydroepiandrosterone (DHEA) market, by Application
Food Industry
Pharmaceuticals Industry
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Dehydroepiandrosterone (DHEA) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Dehydroepiandrosterone (DHEA) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Dehydroepiandrosterone (DHEA) Market Overview
1.1 Dehydroepiandrosterone (DHEA) Product Overview
1.2 Dehydroepiandrosterone (DHEA) Market Segment by Type
1.2.1 Powder
1.2.2 Tablets
1.2.3 Other
1.3 Global Dehydroepiandrosterone (DHEA) Market Size by Type
1.3.1 Global Dehydroepiandrosterone (DHEA) Market Size Overview by Type (2018-2029)
1.3.2 Global Dehydroepiandrosterone (DHEA) Historic Market Size Review by Type (2018-2023)
1.3.3 Global Dehydroepiandrosterone (DHEA) Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Dehydroepiandrosterone (DHEA) Sales Breakdown by Type (2018-2023)
1.4.2 Europe Dehydroepiandrosterone (DHEA) Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Dehydroepiandrosterone (DHEA) Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Dehydroepiandrosterone (DHEA) Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Dehydroepiandrosterone (DHEA) Sales Breakdown by Type (2018-2023)
2 Global Dehydroepiandrosterone (DHEA) Market Competition by Company
2.1 Global Top Players by Dehydroepiandrosterone (DHEA) Sales (2018-2023)
2.2 Global Top Players by Dehydroepiandrosterone (DHEA) Revenue (2018-2023)
2.3 Global Top Players by Dehydroepiandrosterone (DHEA) Price (2018-2023)
2.4 Global Top Manufacturers Dehydroepiandrosterone (DHEA) Manufacturing Base Distribution, Sales Area, Product Type
2.5 Dehydroepiandrosterone (DHEA) Market Competitive Situation and Trends
2.5.1 Dehydroepiandrosterone (DHEA) Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Dehydroepiandrosterone (DHEA) Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Dehydroepiandrosterone (DHEA) as of 2022)
2.7 Date of Key Manufacturers Enter into Dehydroepiandrosterone (DHEA) Market
2.8 Key Manufacturers Dehydroepiandrosterone (DHEA) Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Dehydroepiandrosterone (DHEA) Status and Outlook by Region
3.1 Global Dehydroepiandrosterone (DHEA) Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Dehydroepiandrosterone (DHEA) Historic Market Size by Region
3.2.1 Global Dehydroepiandrosterone (DHEA) Sales in Volume by Region (2018-2023)
3.2.2 Global Dehydroepiandrosterone (DHEA) Sales in Value by Region (2018-2023)
3.2.3 Global Dehydroepiandrosterone (DHEA) Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Dehydroepiandrosterone (DHEA) Forecasted Market Size by Region
3.3.1 Global Dehydroepiandrosterone (DHEA) Sales in Volume by Region (2024-2029)
3.3.2 Global Dehydroepiandrosterone (DHEA) Sales in Value by Region (2024-2029)
3.3.3 Global Dehydroepiandrosterone (DHEA) Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Dehydroepiandrosterone (DHEA) by Application
4.1 Dehydroepiandrosterone (DHEA) Market Segment by Application
4.1.1 Food Industry
4.1.2 Pharmaceuticals Industry
4.1.3 Other
4.2 Global Dehydroepiandrosterone (DHEA) Market Size by Application
4.2.1 Global Dehydroepiandrosterone (DHEA) Market Size Overview by Application (2018-2029)
4.2.2 Global Dehydroepiandrosterone (DHEA) Historic Market Size Review by Application (2018-2023)
4.2.3 Global Dehydroepiandrosterone (DHEA) Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Dehydroepiandrosterone (DHEA) Sales Breakdown by Application (2018-2023)
4.3.2 Europe Dehydroepiandrosterone (DHEA) Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Dehydroepiandrosterone (DHEA) Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Dehydroepiandrosterone (DHEA) Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Dehydroepiandrosterone (DHEA) Sales Breakdown by Application (2018-2023)
5 North America Dehydroepiandrosterone (DHEA) by Country
5.1 North America Dehydroepiandrosterone (DHEA) Historic Market Size by Country
5.1.1 North America Dehydroepiandrosterone (DHEA) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Dehydroepiandrosterone (DHEA) Sales in Volume by Country (2018-2023)
5.1.3 North America Dehydroepiandrosterone (DHEA) Sales in Value by Country (2018-2023)
5.2 North America Dehydroepiandrosterone (DHEA) Forecasted Market Size by Country
5.2.1 North America Dehydroepiandrosterone (DHEA) Sales in Volume by Country (2024-2029)
5.2.2 North America Dehydroepiandrosterone (DHEA) Sales in Value by Country (2024-2029)
6 Europe Dehydroepiandrosterone (DHEA) by Country
6.1 Europe Dehydroepiandrosterone (DHEA) Historic Market Size by Country
6.1.1 Europe Dehydroepiandrosterone (DHEA) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Dehydroepiandrosterone (DHEA) Sales in Volume by Country (2018-2023)
6.1.3 Europe Dehydroepiandrosterone (DHEA) Sales in Value by Country (2018-2023)
6.2 Europe Dehydroepiandrosterone (DHEA) Forecasted Market Size by Country
6.2.1 Europe Dehydroepiandrosterone (DHEA) Sales in Volume by Country (2024-2029)
6.2.2 Europe Dehydroepiandrosterone (DHEA) Sales in Value by Country (2024-2029)
7 Asia-Pacific Dehydroepiandrosterone (DHEA) by Region
7.1 Asia-Pacific Dehydroepiandrosterone (DHEA) Historic Market Size by Region
7.1.1 Asia-Pacific Dehydroepiandrosterone (DHEA) Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Dehydroepiandrosterone (DHEA) Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Dehydroepiandrosterone (DHEA) Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Dehydroepiandrosterone (DHEA) Forecasted Market Size by Region
7.2.1 Asia-Pacific Dehydroepiandrosterone (DHEA) Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Dehydroepiandrosterone (DHEA) Sales in Value by Region (2024-2029)
8 Latin America Dehydroepiandrosterone (DHEA) by Country
8.1 Latin America Dehydroepiandrosterone (DHEA) Historic Market Size by Country
8.1.1 Latin America Dehydroepiandrosterone (DHEA) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Dehydroepiandrosterone (DHEA) Sales in Volume by Country (2018-2023)
8.1.3 Latin America Dehydroepiandrosterone (DHEA) Sales in Value by Country (2018-2023)
8.2 Latin America Dehydroepiandrosterone (DHEA) Forecasted Market Size by Country
8.2.1 Latin America Dehydroepiandrosterone (DHEA) Sales in Volume by Country (2024-2029)
8.2.2 Latin America Dehydroepiandrosterone (DHEA) Sales in Value by Country (2024-2029)
9 Middle East and Africa Dehydroepiandrosterone (DHEA) by Country
9.1 Middle East and Africa Dehydroepiandrosterone (DHEA) Historic Market Size by Country
9.1.1 Middle East and Africa Dehydroepiandrosterone (DHEA) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Dehydroepiandrosterone (DHEA) Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Dehydroepiandrosterone (DHEA) Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Dehydroepiandrosterone (DHEA) Forecasted Market Size by Country
9.2.1 Middle East and Africa Dehydroepiandrosterone (DHEA) Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Dehydroepiandrosterone (DHEA) Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Natrol
10.1.1 Natrol Company Information
10.1.2 Natrol Introduction and Business Overview
10.1.3 Natrol Dehydroepiandrosterone (DHEA) Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Natrol Dehydroepiandrosterone (DHEA) Products Offered
10.1.5 Natrol Recent Development
10.2 GNC
10.2.1 GNC Company Information
10.2.2 GNC Introduction and Business Overview
10.2.3 GNC Dehydroepiandrosterone (DHEA) Sales, Revenue and Gross Margin (2018-2023)
10.2.4 GNC Dehydroepiandrosterone (DHEA) Products Offered
10.2.5 GNC Recent Development
10.3 Nature’s Bounty
10.3.1 Nature’s Bounty Company Information
10.3.2 Nature’s Bounty Introduction and Business Overview
10.3.3 Nature’s Bounty Dehydroepiandrosterone (DHEA) Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Nature’s Bounty Dehydroepiandrosterone (DHEA) Products Offered
10.3.5 Nature’s Bounty Recent Development
10.4 Jarrow Formulas
10.4.1 Jarrow Formulas Company Information
10.4.2 Jarrow Formulas Introduction and Business Overview
10.4.3 Jarrow Formulas Dehydroepiandrosterone (DHEA) Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Jarrow Formulas Dehydroepiandrosterone (DHEA) Products Offered
10.4.5 Jarrow Formulas Recent Development
10.5 Acetar Bio-Tech
10.5.1 Acetar Bio-Tech Company Information
10.5.2 Acetar Bio-Tech Introduction and Business Overview
10.5.3 Acetar Bio-Tech Dehydroepiandrosterone (DHEA) Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Acetar Bio-Tech Dehydroepiandrosterone (DHEA) Products Offered
10.5.5 Acetar Bio-Tech Recent Development
10.6 Shanghai Jinli Biotech
10.6.1 Shanghai Jinli Biotech Company Information
10.6.2 Shanghai Jinli Biotech Introduction and Business Overview
10.6.3 Shanghai Jinli Biotech Dehydroepiandrosterone (DHEA) Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Shanghai Jinli Biotech Dehydroepiandrosterone (DHEA) Products Offered
10.6.5 Shanghai Jinli Biotech Recent Development
10.7 Lisi (Xian) Bio-Tech
10.7.1 Lisi (Xian) Bio-Tech Company Information
10.7.2 Lisi (Xian) Bio-Tech Introduction and Business Overview
10.7.3 Lisi (Xian) Bio-Tech Dehydroepiandrosterone (DHEA) Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Lisi (Xian) Bio-Tech Dehydroepiandrosterone (DHEA) Products Offered
10.7.5 Lisi (Xian) Bio-Tech Recent Development
10.8 Schiff Vitamins
10.8.1 Schiff Vitamins Company Information
10.8.2 Schiff Vitamins Introduction and Business Overview
10.8.3 Schiff Vitamins Dehydroepiandrosterone (DHEA) Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Schiff Vitamins Dehydroepiandrosterone (DHEA) Products Offered
10.8.5 Schiff Vitamins Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Dehydroepiandrosterone (DHEA) Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Dehydroepiandrosterone (DHEA) Industrial Chain Analysis
11.4 Dehydroepiandrosterone (DHEA) Market Dynamics
11.4.1 Dehydroepiandrosterone (DHEA) Industry Trends
11.4.2 Dehydroepiandrosterone (DHEA) Market Drivers
11.4.3 Dehydroepiandrosterone (DHEA) Market Challenges
11.4.4 Dehydroepiandrosterone (DHEA) Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Dehydroepiandrosterone (DHEA) Distributors
12.3 Dehydroepiandrosterone (DHEA) Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
